Psoriasis uncovered – measuring burden of disease impact in a survey of Australians with psoriasis

Abstract

Psoriasis imposes a significant psychosocial burden on the lives of patients, including a profound impact upon their personal and professional relationships, social interactions and quality of life, to a degree comparable to other serious chronic conditions. This study highlights the importance of collaboration between primary and specialist health-care providers in developing patient management strategies that address the spectrum of physical and psychological manifestations associated with psoriasis.

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis

“…[P9: prescribed topical therapy but using herbal therapies] reducing or ending participation in physical activities. These factors are recognized problems in this population [43][44][45] and all were perceived as contributing to ongoing psychological distress. The need to manage psoriasis symptoms with prescribed medication conflicted with the need to manage concerns about adverse effects.…”

Patient perceptions of clear/almost clear skin in moderate‐to‐severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey

“…[20][21][22][23][24][25] The study reported here took an innovative approach of evaluating broad aspects of patient experience, encompassing questions on symptom severity, treatment efficacy, and the impact of psoriasis on aspects of healthrelated QoL, such as sleep, work productivity and relationships. [20][21][22][23][24][25] The study reported here took an innovative approach of evaluating broad aspects of patient experience, encompassing questions on symptom severity, treatment efficacy, and the impact of psoriasis on aspects of healthrelated QoL, such as sleep, work productivity and relationships.…”

“…While patient perceptions of and attitudes about psoriasis and its treatment are considered increasingly paramount in managing the disease, few studies have systematically elicited patients' perspectives on a large scale. [20][21][22][23][24][25] The study reported here took an innovative approach of evaluating broad aspects of patient experience, encompassing questions on symptom severity, treatment efficacy, and the impact of psoriasis on aspects of healthrelated QoL, such as sleep, work productivity and relationships. The survey extended globally, recruiting 8338 participants from 31 countries.…”

‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well®patient materials mixed‐methods feasibility study

“…1 It is associated with high levels of physical and psychological disability, 2-5 comorbidities 6-10 and significant life impact. 11,12 While individuals with psoriasis have additional risk factors for 13 and higher mortality from 14 cardiovascular disease, recent evidence suggests that psoriasis in the absence of inflammatory arthritis is not an independent risk factor. 13 Unhealthy lifestyle behaviours [15][16][17][18][19][20] and obesity 21 are more common in individuals with psoriasis, complicating understanding of comorbidities 13,18 and contributing to risks of psoriasis onset and/or exacerbation, 16,[22][23][24][25][26][27] although patients and nonspecialist clinicians may be unaware of these associations.…”

“…Psoriasis is a complex, long‐term inflammatory skin condition affecting at least 2% of the U.K. population . It is associated with high levels of physical and psychological disability, comorbidities and significant life impact . While individuals with psoriasis have additional risk factors for and higher mortality from cardiovascular disease, recent evidence suggests that psoriasis in the absence of inflammatory arthritis is not an independent risk factor …”